Rocket Pharmaceuticals, Inc. (RCKT)
3.01
+0.01
(+0.33%)
USD |
NASDAQ |
May 27, 15:00
Rocket Pharmaceuticals Free Cash Flow : -179.81M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| AnaptysBio, Inc. | 4.409M |
| Arcus Biosciences, Inc. | -489.00M |
| Replimune Group, Inc. | -283.27M |
| ACADIA Pharmaceuticals, Inc. | 113.59M |
| Alnylam Pharmaceuticals, Inc. | 641.34M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -45.39M |
| Cash from Investing (Quarterly) | 17.45M |
| Cash from Financing (Quarterly) | -0.001M |
| Free Cash Flow Per Share (Quarterly) | -0.4056 |
| Free Cash Flow to Equity (Quarterly) | -45.37M |
| Free Cash Flow to Firm (Quarterly) | -45.01M |
| Free Cash Flow Yield | -53.51% |